Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Ribosome profiling of CLL patient samples

ABSTRACT: Ribosome profiling of CLL patient samples

PROVIDER: PRJEB23398 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	ERR2193150.fastq.gz	Fastqsanger.gz
	ERR2193151.fastq.gz	Fastqsanger.gz
	ERR2193152.fastq.gz	Fastqsanger.gz
	ERR2193153.fastq.gz	Fastqsanger.gz
	ERR2193154.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 14

Similar Datasets

Ribosome profiling of CLL patient samples

Project description:The functional consequences of many of the genetic changes, or combinations of genetic changes, in chronic lymphocytic leukaemia (CLL) are not known, but it is essential to discover these in order to understand the biology of the disease and the causes of individual variation in response to novel and conventional treatments. In this proof-of-principle study the translational landscape of CLL was determined for the first time by ribosome profiling. Individual variation in response to stimuli from the tumour microenvironment has not been systematically explored previously, but is likely to influence response to treatment and survival.

2018-08-07 | E-MTAB-6196 | biostudies-arrayexpress

scRNAseq of longitidunally acquired samples from a CLL patient

Project description:We collected three timepoint blood samples from a CLL patient underwent BTK inhibitor treatment. We performed single cell RNA sequencing on these samples to track expression heterogeneity of malignant B-cell populations over time.

2021-10-22 | GSE186150 | GEO

Gene expression analysis of 6 MCL and 18 CLL patient samples

Project description:Microarray-based gene expression analysis identified genes differentially expressed in 6 MCL and 18 CLL patient samples compared in independent analyses to CD19 selected healthy donor B-cell samples.

2010-06-03 | GSE16411 | GEO

scRNAseq of longitidunally acquired samples from a CLL patient

Project description:scRNAseq of longitidunally acquired samples from a CLL patient

| PRJNA772744 | ENA

Expression data from CLL patient samples investigated to define biologic heterogeneity.

Project description:Expression data from CLL patient samples investigated to define biologic heterogeneity.

| PRJNA523004 | ENA

miRNA profiling of CLL

Project description:miRNA profiling of CLL

| PRJNA508753 | ENA

Combined chemosensitivity and chromatin profiling prioritizes drug combinations in CLL

Project description:The Bruton tyrosine kinase (BTK) inhibitor ibrutinib has substantially improved therapeutic options for chronic lymphocytic leukemia (CLL). Although ibrutinib is not curative, it has a profound effect on CLL cells and may create new pharmacologically exploitable vulnerabilities. To identify such vulnerabilities, we developed a systematic approach that combines epigenome profiling (charting the gene-regulatory basis of cell state) with single-cell chemosensitivity profiling (quantifying cell-type-specific drug response) and bioinformatic data integration. By applying our method to a cohort of matched patient samples collected before and during ibrutinib therapy, we identified characteristic ibrutinib-induced changes that provide a starting point for the rational design of ibrutinib combination therapies. Specifically, we observed and validated preferential sensitivity to proteasome, PLK1, and mTOR inhibitors during ibrutinib treatment. More generally, our study establishes a broadly applicable method for investigating treatment-specific vulnerabilities by integrating the complementary perspectives of epigenetic cell states and phenotypic drug responses in primary patient samples.

2019-01-26 | GSE100672 | GEO

Analysis of CD38+ and CD38- sub-clones derived from the same CLL patient

Project description:CD38 expression is an important prognostic marker in CLL with high levels of CD38 associated with shorter overall survival. In this study, we used gene expression profiling and protein analysis of highly purified cell-sorted CD38+ and CD38- chronic lymphocytic leukemia cells to elucidate a molecular basis for the association between CD38 expression and inferior clinical outcome. Paired CD38+ and CD38- CLL cells derived from the same patient were shown to be monoclonal by VH gene sequencing but despite this, CD38+ CLL cells possessed a distinct gene expression profile when compared with their CD38- sub-clones. Keywords: Sub-clonal analysis of CLL cells derived from the same leukemia sample

2006-11-23 | GSE6321 | GEO

Analysis of phosphorylation sites in CLL samples

Project description:The profiling of B-cell chronic lymphocytic leukemia (B-CLL) cells at the protein level is still a major goal for advancing targeted personalized therapies. Understanding how B cells become malignant would be supported by the description of predicted responses to kinase inhibitors as nearly all cancers are guided by deregulation of protein kinase networks. In this sense, the present project looks for the profiling of the phosphopetides present in the B-CLL proteins together with the full characterization of their proteome.

2025-05-13 | PXD005997 | Pride

Transcriptomic and epigenetic profiling of SCLC patient samples.

Project description:Transcriptomic and epigenetic profiling of SCLC patient samples.

| PRJNA1015358 | ENA